Atlas Trials

Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab

Clinical trial NCT03960268 · COMPLETED

Trial details

NCT number
NCT03960268
Sponsor
Rockefeller University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2019-05-28
Primary completion
2020-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.